Amedeo's Top 20

Amedeo Smart

Independent Medical Education

26 June 2023

Multidisciplinary Journal Club

  1. Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, et al.
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    N Engl J Med 2023.

  1. Miah IP, Holl DC, Blaauw J, Lingsma HF, et al.
    Dexamethasone versus Surgery for Chronic Subdural Hematoma.
    N Engl J Med 2023;388:2230-2240.

  2. Agrawal M, Ebert AC, Poulsen G, Ungaro RC, et al.
    Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based cohort study.
    Gastroenterology 2023.

  3. Ellis RJ, Brajcich BC, Bertens KA, Chan CHF, et al.
    Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.
    Ann Surg 2023.

  4. Hutchinson PJ, Adams H, Mohan M, Devi BI, et al.
    Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma.
    N Engl J Med 2023;388:2219-2229.

  1. Knopman DS, Hershey L.
    Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift.
    Neurology 2023.

  2. Michalski JM, Winter KA, Prestidge BR, Sanda MG, et al.
    Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
    J Clin Oncol 2023.

  3. Palacios N, Wilkinson J, Bjornevik K, Schwarzschild MA, et al.
    Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
    Ann Neurol 2023.

  4. El Chaer F, Hourigan CS, Zeidan AM.
    How I treat AML incorporating the updated classifications and guidelines.
    Blood 2023;141:2813-2823.

  5. Liu FC, Luk KC, Chen YC.
    Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
    Osteoporos Int 2023.

  1. Park JS, Lee SM, Choi GS, Park SY, et al.
    Comparison of Laparoscopic Versus Robot-Assisted Surgery for Rectal Cancers: The COLRAR Randomized Controlled Trial.
    Ann Surg 2023;278:31-38.

  2. Armand P, Zinzani PL, Lee HJ, Johnson NA, et al.
    Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy in relapsed/refractory classical Hodgkin lymphoma.
    Blood 2023.

  3. Solans BP, Imperial MZ, Olugbosi M, Savic RM, et al.
    Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.
    Clin Infect Dis 2023;76:1903-1910.

  4. Yan L, Zhen Y, Li Y, Li X, et al.
    Five-year Outcome Between Radiofrequency Ablation vs. Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab 2023.

  5. Parente A, Tirotta F, Pini A, Eden J, et al.
    Machine perfusion techniques for liver transplantation - A meta-analysis of the first seven randomized controlled trials.
    J Hepatol 2023.

  1. Westgeest AC, Buis DTP, Sigaloff KCE, Ruffin F, et al.
    Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.
    Clin Infect Dis 2023.

  2. Ortiz-Brizuela E, Apriani L, Mukherjee T, Lachapelle-Chisholm S, et al.
    Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis 2023.

  3. Smith KM, Wirrell EC, Andrade DM, Choi H, et al.
    Management of epilepsy with eyelid myoclonia: results of an international expert consensus panel.
    Epilepsia 2023.

  4. Coles CE, Haviland JS, Kirby AM, Griffin CL, et al.
    Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
    Lancet 2023.

  5. Rodin D, Sutradhar R, Jerzak KJ, Hahn E, et al.
    Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery.
    Breast Cancer Res Treat 2023.


more..

Privacy Policy